Chinese drug developer Xgene Pharmaceutical Group and Wuxi Biortus Biosciences have secured funding.
Continue reading this premium story with a subscription to DealStreetAsia.
SubscribeAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com